Hélène Lasolle

Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016

Ann McCormack, Stephan Petersenn, Vera Popović et al. · European Journal of Endocrinology · 2018 · 282 citations · Full text

Medicine, Endocrinology, Oncology +17

Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas

Hélène Lasolle, Christine Cortet, Frédéric Castinetti et al. · European Journal of Endocrinology · 2017 · 141 citations

Medicine, Endocrinology, Oncology +11

Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients

Pia Burman, Jacqueline Trouillas, Marco Losa et al. · European Journal of Endocrinology · 2022 · 104 citations · Full text

Medicine, Endocrinology, Oncology +17

Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study

Massimo Terzolo, Paola Perotti, Rossella Libé et al. · The Lancet Diabetes & Endocrinology · 2023 · 75 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France

Alexandre Dormoy, Magalie Haissaguerre, Géraldine Vitellius et al. · The Journal of Clinical Endocrinology & Metabolism · 2022 · 64 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +16